Circio logoCircio logo

  • About
    About
    Close
      • About Circio
      • Pipeline
      • Management Team
      • Board of Directors
      • Careers
  • circRNA
    circRNA
    Close
      • Circio AB
      • circVec platform
  • Clinical programs
    Clinical programs
    Close
      • ONCOS-102
      • KRAS program
      • Publications
  • Partnering
  • Investors
    Investors
    Close
      • Press releases
      • Events
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
        • General Meetings
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Articles of Association
      • Contact
  • Media
    Media
    Close
      • Press releases
      • Events
      • Subscribe
      • Contact
  • Contacts
    Contacts
    Close
      • Offices
      • Investors & Media
    • About
      • About Circio
      • Our pipeline
      • Management Team
      • Board of Directors
      • Collaborations
      • Careers
    • circRNA
      • Circio AB
      • circVec platform
    • Clinical programs
      • ONCOS-102
      • KRAS program
      • Publications
    • Partnering
      • Partnering
    • Investors
      • Press releases
      • Events
      • Financial Reports
      • Presentations
      • Prospectus
      • Debt
      • Share information
        • Share facts
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
      • General Meetings
      • Board of Directors
      • Nomination Committee
      • Committees
      • Management
      • Articles of Association
      • Contact
      • Subscribe
      • Contact
    • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
    • Contacts
      • Offices
      • Investors & Media
    All press releases
    • Press releases - Regulatory
    • Press releases - Non-regulatory
    All years
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    All subjects
    • Corporate news
    • Other
    May 31, 2023
    Press release - Non-regulatory

    Circio invites to a company update on Thursday 15 June 2023

    May 26, 2023
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    May 25, 2023
    Press release - Regulatory

    Circio Holding ASA – New name registered

    May 23, 2023
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    May 22, 2023
    Press release - Regulatory

    Targovax ASA: Minutes from the Annual General Meeting

    May 16, 2023
    Press release - Non-regulatory

    Circio: Link to recording and presentation from Company update 16[th] May 2023

    May 12, 2023
    Press release - Regulatory

    Circio invites to a company update on Tuesday 16 May 2023

    May 3, 2023
    Press release - Regulatory

    Targovax ASA – Correction of the proxy form attached to the notice of the Annual General Meeting

    May 3, 2023
    Press release - Non-regulatory

    Circio: circRNA poster to be presented at the ASGCT Annual Meeting

    April 28, 2023
    Press release - Regulatory

    Targovax ASA – Notice of Annual General Meeting

    April 19, 2023
    Press release - Regulatory

    Targovax to rebrand as Circio, an innovator in next generation circular RNA therapeutics

    April 13, 2023
    Press release - Regulatory

    Targovax ASA: Annual Report 2022

    April 13, 2023
    Press release - Non-regulatory

    Targovax ASA: Registration of share capital increase following conversion of convertible bonds

    April 13, 2023
    Press release - Non-regulatory

    Financial calendar

    March 30, 2023
    Press release - Non-regulatory

    Targovax ASA: Requested Conversion of Convertible Bonds

    March 15, 2023
    Press release - Non-regulatory

    Targovax ASA: circRNA poster to be presented at the AACR Annual Meeting

    March 14, 2023
    Press release - Non-regulatory

    Targovax: First patient dosed with TG01 in the USA

    March 9, 2023
    Press release - Regulatory

    Targovax ASA – First Tranche of Convertible Bonds

    March 9, 2023
    Press release - Regulatory

    Targovax ASA: Minutes from the Extraordinary General Meeting

    March 7, 2023
    Press release - Regulatory

    Targovax to prioritize resources on unlocking the potential of its circRNA platform

    March 6, 2023
    Press release - Regulatory

    Targovax ASA – Additional information prior to the Extraordinary General Meeting

    March 6, 2023
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following settlement of restricted stock units

    March 2, 2023
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insiders pertaining to RSUs

    March 2, 2023
    Press release - Regulatory

    Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

    March 1, 2023
    Press release - Regulatory

    Targovax ASA – Additional information prior to the Extraordinary General Meeting

    February 23, 2023
    Press release - Regulatory

    Targovax invites to Q&A webcast regarding convertible bond financing

    February 16, 2023
    Press release - Regulatory

    Targovax ASA – Notice of Extraordinary General Meeting

    February 16, 2023
    Press release - Regulatory

    Targovax ASA: Fourth quarter 2022 results

    February 16, 2023
    Press release - Regulatory

    Targovax announces financing of up to NOK 300m over three years to advance its clinical cancer programs & pre-clinical circular RNA platform

    February 8, 2023
    Press release - Regulatory

    Targovax ASA: Invitation to Targovax’s fourth quarter 2022 presentation, Thursday 16 February

    December 22, 2022
    Press release - Non-regulatory

    Targovax announces that the TG01 study in multiple myeloma at Oslo University Hospital has received regulatory approvals to proceed

    December 20, 2022
    Press release - Regulatory

    Targovax ASA issues options to employees

    December 15, 2022
    Press release - Non-regulatory

    Targovax announces clinical trial collaboration with Agenus to test TG mutant RAS vaccination in pancreatic cancer

    December 7, 2022
    Press release - Non-regulatory

    Targovax to present and attend at upcoming conferences

    November 10, 2022
    Press release - Non-regulatory

    Hubro Therapeutics AS acquires GM-CSF vaccine adjuvant from Targovax ASA in asset purchase agreement

    November 3, 2022
    Press release - Regulatory

    Targovax ASA: Third quarter 2022 results

    October 26, 2022
    Press release - Regulatory

    Invitation to Targovax’s third quarter 2022 presentation, Thursday 3 November

    October 20, 2022
    Press release - Non-regulatory

    The ONCOS-102 phase 1b melanoma study is published in the prestigious scientific journal Clinical Cancer Research – with updated publication info

    October 20, 2022
    Press release - Non-regulatory

    The ONCOS-102 phase 1b melanoma study is published in the prestigious scientific journal Clinical Cancer Research

    October 5, 2022
    Press release - Non-regulatory

    The ONCOS-102 phase 1b melanoma study selected for oral presentation at the SITC 2022 annual meeting

    September 27, 2022
    Press release - Non-regulatory

    Targovax receives approval to proceed with the ONCOS-102 phase 2 melanoma study from the US FDA

    September 26, 2022
    Press release - Non-regulatory

    Reminder: Targovax to host Investor Event 27 September

    September 19, 2022
    Press release - Non-regulatory

    Targovax to host Investor Event: Meet the Management on 27 September

    September 12, 2022
    Press release - Non-regulatory

    Targovax to present at upcoming conferences

    August 18, 2022
    Press release - Regulatory

    Targovax ASA: Second quarter and first half year 2022 results

    August 11, 2022
    Press release - Non-regulatory

    Targovax ASA: Invitation to Targovax’s second quarter and first half 2022 presentation, Thursday 18 August

    July 4, 2022
    Press release - Regulatory

    Targovax: Completion of drop-down demerger

    June 23, 2022
    Press release - Non-regulatory

    Targovax announces that the FDA has granted authorization to initiate clinical trials with the enhanced TG01 RAS vaccine in the USA

    June 23, 2022
    Press release - Non-regulatory

    Targovax: FDA gir tillatelse til å starte kliniske studier med ny og forbedret TG01 kreftvaksine i USA

    June 7, 2022
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following settlement of restricted stock units and exercise of employee options

    May 31, 2022
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insiders pertaining to RSUs

    May 31, 2022
    Press release - Regulatory

    Targovax ASA: Exercise of options, settlement of restricted stock units and resolutions to increase the share capital

    May 27, 2022
    Press release - Non-regulatory

    Targovax announces publication of the two abstracts accepted for poster presentation at ASCO 2022

    May 12, 2022
    Press release - Regulatory

    Targovax ASA: First quarter 2022 results

    May 11, 2022
    Press release - Regulatory

    Targovax announces clinical collaboration with Agenus for upcoming ONCOS-102 phase 2 melanoma trial

    May 11, 2022
    Press release - Non-regulatory

    Targovax to present at upcoming conferences

    May 10, 2022
    Press release - Non-regulatory

    Targovax and Oslo University Hospital announce collaboration to test TG mutant RAS vaccination in multiple myeloma

    May 3, 2022
    Press release - Non-regulatory

    Targovax ASA: Invitation to presentation of Targovax’s first quarter 2022 results, Thursday 12 May

    April 28, 2022
    Press release - Non-regulatory

    Targovax ASA: Two ONCOS-102 abstracts accepted for ASCO

    April 26, 2022
    Press release - Non-regulatory

    Targovax to present at 5th Neoantigen Summit Europe in Amsterdam

    April 21, 2022
    Press release - Non-regulatory

    Targovax ASA announces the appointment of two new Board Directors

    April 20, 2022
    Press release - Regulatory

    Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

    April 20, 2022
    Press release - Regulatory

    Targovax ASA: Minutes from the Annual General Meeting

    March 30, 2022
    Press release - Regulatory

    Notice of Annual General Meeting

    March 14, 2022
    Press release - Regulatory

    Targovax – Proposal to implement a drop-down demerger

    March 9, 2022
    Press release - Regulatory

    Targovax ASA: Annual Report 2021

    March 9, 2022
    Press release - Non-regulatory

    Targovax ASA: Poster presentation at the AACR Annual Meeting

    March 8, 2022
    Press release - Regulatory

    Targovax ASA: Registration of share capital increases following exercise of options

    March 7, 2022
    Press release - Regulatory

    Targovax ASA: GRANT OF SHARE OPTIONS TO NEW CFO

    March 7, 2022
    Press release - Non-regulatory

    Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 STIMULON™

    March 2, 2022
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

    March 2, 2022
    Press release - Regulatory

    Targovax ASA: Exercise of options under LTI program, settlement of RSUs and resolution to increase the share capital

    February 28, 2022
    Press release - Regulatory

    Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer

    February 17, 2022
    Press release - Regulatory

    Targovax ASA: Fourth quarter 2021 results

    February 9, 2022
    Press release - Regulatory

    Targovax ASA: Invitation to presentation of Targovax’s fourth quarter 2021 results, Thursday 17 February

    February 1, 2022
    Press release - Non-regulatory

    Targovax inngår forskningssamarbeid med Karolinska Institutet (Norwegian)

    February 1, 2022
    Press release - Regulatory

    Targovax and Prof. Michael Uhlin at Karolinska Institutet enter research collaboration

    January 17, 2022
    Press release - Non-regulatory

    Targovax granted Patents for ONCOS-102 in combination with chemotherapy in China and Japan

    January 12, 2022
    Press release - Regulatory

    Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway

    December 23, 2021
    Press release - Regulatory

    Targovax ASA issues options to employees

    December 22, 2021
    Press release - Regulatory

    Targovax ASA – Registration of share capital increase pertaining to the Rights Issue

    December 20, 2021
    Press release - Non-regulatory

    Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma

    December 16, 2021
    Press release - Regulatory

    Targovax ASA: Primary insider share purchase

    December 16, 2021
    Press release - Regulatory

    Targovax ASA: Primary insiders share purchase

    December 16, 2021
    Press release - Regulatory

    Targovax ASA: Primary insiders share purchase

    December 15, 2021
    Press release - Regulatory

    Targovax awarded NOK 9.8m research grant by the Research Council of Norway towards the TG mutant RAS program

    December 15, 2021
    Press release - Regulatory

    Targovax ASA – Final results of the rights issue

    December 14, 2021
    Press release - Regulatory

    Targovax ASA – Preliminary results of the rights issue

    December 14, 2021
    Press release - Regulatory

    Targovax ASA – The subscription period for the rights issue expires today

    December 13, 2021
    Press release - Non-regulatory

    Targovax to present at DNB’s 12[th] Nordic Healthcare Conference

    December 10, 2021
    Press release - Regulatory

    Targovax ASA – Exercise of subscription rights in the rights issue by close associate of a primary insider

    December 10, 2021
    Press release - Regulatory

    Targovax ASA – Last day of trading in subscription rights

    December 10, 2021
    Press release - Regulatory

    Targovax ASA – Exercise of subscription rights in the rights issue by close associate of a primary insider

    December 5, 2021
    Press release - Regulatory

    Shareholder disclosure by Radforsk Investeringsstiftelse

    December 1, 2021
    Press release - Regulatory

    Targovax ASA – Exercise of subscription rights in the rights issue by close associate of a primary insider

    November 30, 2021
    Press release - Regulatory

    Targovax ASA – Exercise of subscription rights in the rights issue by close associate of a primary insider

    November 30, 2021
    Press release - Regulatory

    Targovax ASA – Receipt of subscription rights in the rights issue by primary insiders and their close associates

    November 30, 2021
    Press release - Regulatory

    Targovax ASA – Commencement of the subscription period for the rights issue

    November 29, 2021
    Press release - Regulatory

    Targovax ASA – Approval and publication of the prospectus for the rights issue

    November 26, 2021
    Press release - Regulatory

    TRVX – Ex. subscription rights today

    November 25, 2021
    Press release - Regulatory

    Targovax ASA – Rights issue approved by the extraordinary general meeting

    November 24, 2021
    Press release - Regulatory

    Targovax ASA – Updated key information relating to the preferential rights issue

    November 24, 2021
    Press release - Regulatory

    Targovax ASA – Terms of the fully underwritten rights issue

    November 18, 2021
    Press release - Non-regulatory

    Targovax invites to webcast presentation in Norwegian

    November 9, 2021
    Press release - Non-regulatory

    Targovax announces two posters at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

    November 4, 2021
    Press release - Regulatory

    Targovax ASA – Key information relating to the preferential rights issue

    November 4, 2021
    Press release - Regulatory

    Targovax ASA – Notice of extraordinary general meeting – Fully underwritten rights issue

    November 4, 2021
    Press release - Regulatory

    Targovax ASA: Third quarter 2021 results

    October 27, 2021
    Press release - Regulatory

    Targovax ASA: PDMR notices

    October 27, 2021
    Press release - Non-regulatory

    Targovax ASA: Invitation to presentation of Targovax’s third quarter 2021 results, Thursday 4 November

    October 25, 2021
    Press release - Non-regulatory

    Targovax: Presentation material for today’s webcast

    October 22, 2021
    Press release - Non-regulatory

    Targovax invites to webcast presentation on Xtrainvestor

    October 21, 2021
    Press release - Regulatory

    Targovax ASA: GRANT OF SHARE OPTIONS

    October 20, 2021
    Press release - Regulatory

    Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO

    October 19, 2021
    Press release - Non-regulatory

    Targovax to present at upcoming conferences

    October 6, 2021
    Press release - Non-regulatory

    Targovax ASA: Two abstracts accepted at the SITC Congress

    October 3, 2021
    Press release - Regulatory

    Targovax ASA issues options to new member of management

    September 30, 2021
    Press release - Non-regulatory

    Targovax ASA appoints Ola Melin as Head of Manufacturing

    September 24, 2021
    Press release - Non-regulatory

    Targovax granted European Patent for ONCOS-102 in combination with chemotherapy

    September 16, 2021
    Press release - Non-regulatory

    Targovax ASA: Poster at European Society for Medical Oncology (ESMO)

    August 27, 2021
    Press release - Non-regulatory

    Targovax ASA: Abstract on ONCOS-102 phase 1 trial in advanced PD1 refractory melanoma is accepted at ESMO Congress

    August 18, 2021
    Press release - Regulatory

    Targovax ASA: second quarter and first half year 2021 results

    August 16, 2021
    Press release - Non-regulatory

    Targovax to present at upcoming scientific conferences

    August 9, 2021
    Press release - Regulatory

    Targovax ASA: Invitation to presentation of Targovax’s second quarter and first half 2021 results, Wednesday 18 August

    July 9, 2021
    Press release - Regulatory

    Targovax announces resignation of Chief Financial Officer, Torbjørn Furuseth

    July 2, 2021
    Press release - Regulatory

    Targovax ASA issues options to new member of management

    July 1, 2021
    Press release - Regulatory

    Targovax ASA appoints Dr Lone Ottesen as Chief Development Officer

    June 28, 2021
    Press release - Regulatory

    Targovax to present at the 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition

    June 22, 2021
    Press release - Regulatory

    Targovax receives Fast Track designation for ONCOS-102 in melanoma

    June 17, 2021
    Press release - Regulatory

    Targovax announces completed enrollment in the phase 1/2 trial with ONCOS-102 in combination with durvalumab in patients with advanced colorectal cancer with peritoneal malignancies

    June 14, 2021
    Press release - Regulatory

    Targovax releases presentations of ONCOS-102 mesothelioma 24-month data

    June 10, 2021
    Press release - Regulatory

    Targovax’s ONCOS-102 mesothelioma 24-month data shows class-leading median overall survival

    May 26, 2021
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following the settlement of RSUs

    May 21, 2021
    Press release - Non-regulatory

    Targovax to present at upcoming investor and scientific conferences

    May 19, 2021
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insiders in connection with settlement of RSUs

    May 18, 2021
    Press release - Regulatory

    Targovax ASA: Resolution to increase the share capital following exercise of RSUs

    May 6, 2021
    Press release - Regulatory

    Targovax ASA: First quarter 2021 results

    April 27, 2021
    Press release - Regulatory

    Targovax ASA: Invitation to presentation of Targovax’s first quarter 2021 results, Thursday 6 May

    March 18, 2021
    Press release - Regulatory

    Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

    March 17, 2021
    Press release - Non-regulatory

    Targovax ASA announces new member of the Board

    March 17, 2021
    Press release - Non-regulatory

    Targovax ASA: Minutes from the Annual General Meeting

    March 9, 2021
    Press release - Non-regulatory

    Targovax granted US Patent for ONCOS-102 in combination with checkpoint inhibitors

    March 8, 2021
    Press release - Non-regulatory

    Targovax to present and attend at upcoming investor and scientific conferences

    March 4, 2021
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following exercise of options

    March 1, 2021
    Press release - Regulatory

    Targovax ASA: Exercise of options under LTI program and resolution to increase the share capital

    February 24, 2021
    Press release - Non-regulatory

    Targovax: Proposal for Remuneration Guidelines for Board and Executive Management

    February 23, 2021
    Press release - Non-regulatory

    Continued survival benefit in Targovax’s ONCOS-102 trial in mesothelioma at the 21-month follow-up

    February 18, 2021
    Press release - Non-regulatory

    Reminder: Invitation to Targovax’s Capital Markets Day 18 February 2021

    February 18, 2021
    Press release - Regulatory

    Targovax ASA: Annual Report 2020

    February 18, 2021
    Press release - Regulatory

    Targovax ASA: Fourth quarter 2020 results

    February 17, 2021
    Press release - Non-regulatory

    Notice of Annual General Meeting

    February 15, 2021
    Press release - Non-regulatory

    Targovax receives Fast-Track designation for ONCOS-102

    February 11, 2021
    Press release - Non-regulatory

    Agenda for Targovax’s Capital Markets Day 18 February 2021

    February 10, 2021
    Press release - Non-regulatory

    Targovax and Papyrus Therapeutics enter research collaboration to develop novel ONCOS viruses with receptor tyrosine kinase (RTK) inhibitor functionality

    February 9, 2021
    Press release - Non-regulatory

    SOTIO has stopped collaboration trial with the dendritic cell vaccine DCVAC in combination with ONCOS-102

    January 11, 2021
    Press release - Non-regulatory

    Targovax to present at the H.C. Wainwright Virtual BioConnect 2021 Conference

    January 6, 2021
    Press release - Non-regulatory

    Targovax grants IOVaxis 3 months extension to the exclusive license option for TG mutant RAS vaccines in Greater China and Singapore

    December 23, 2020
    Press release - Regulatory

    Targovax ASA issues options to employees

    December 15, 2020
    Press release - Non-regulatory

    Targovax ASA: Save the date – Capital Markets Day 2021

    December 14, 2020
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following exercise of options

    December 10, 2020
    Press release - Non-regulatory

    Targovax to present at DNB’s 11[th] Annual Nordic Healthcare Conference

    December 8, 2020
    Press release - Regulatory

    Targovax ASA: Exercise of options and resolution to increase the share capital

    December 3, 2020
    Press release - Regulatory

    Targovax ASA: Primary insider share purchase

    December 2, 2020
    Press release - Non-regulatory

    Targovax ASA: Invitation to online presentation at 10:00 CET 2 December

    December 1, 2020
    Press release - Non-regulatory

    Targovax announces impressive objective responses as well as effects on non-injected lesions in ONCOS-102 trial in anti-PD1 refractory melanoma patients

    November 24, 2020
    Press release - Non-regulatory

    Targovax demonstrates encouraging survival data for ONCOS-102 in mesothelioma

    November 17, 2020
    Press release - Non-regulatory

    Targovax to present at Bryan Garnier & Co Virtual European Healthcare Conference

    November 9, 2020
    Press release - Non-regulatory

    Targovax announces poster at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

    November 5, 2020
    Press release - Non-regulatory

    Targovax ASA: third quarter 2020 results

    November 2, 2020
    Press release - Non-regulatory

    Targovax to present at the World Immunotherapy Congress

    October 28, 2020
    Press release - Non-regulatory

    Targovax announces formation of new Scientific Advisory Board

    October 26, 2020
    Press release - Non-regulatory

    Targovax ASA: Invitation to presentation of Targovax’s third quarter 2020 results, Thursday 5 November

    October 22, 2020
    Press release - Regulatory

    TARGOVAX ASA – REGISTRATION OF SHARE CAPITAL INCREASE FOLLOWING THE PRIVATE PLACEMENT

    October 20, 2020
    Press release - Regulatory

    TARGOVAX ASA – NO SUBSEQUENT OFFERING

    October 19, 2020
    Press release - Regulatory

    TARGOVAX ASA – APPROVAL AND PUBLICATION OF PROSPECTUS

    October 19, 2020
    Press release - Non-regulatory

    Targovax announces accepted abstract at SITC

    October 14, 2020
    Press release - Regulatory

    TARGOVAX ASA – NOTIFICATION OF SHAREHOLDING

    October 14, 2020
    Press release - Regulatory

    TARGOVAX ASA – KEY INFORMATION RELATED TO THE SUBSEQUENT OFFERING

    October 14, 2020
    Press release - Regulatory

    TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

    October 14, 2020
    Press release - Regulatory

    TARGOVAX ASA – CONTEMPLATED PRIVATE PLACEMENT

    October 13, 2020
    Press release - Non-regulatory

    Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer

    October 12, 2020
    Press release - Non-regulatory

    Targovax granted European Patent for ONCOS-102 in combination with checkpoint inhibitors

    September 18, 2020
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following settlement of restricted stock units

    September 14, 2020
    Press release - Non-regulatory

    Targovax is invited to present at H.C. Wainwright 22[nd] Annual Global Investment Conference

    September 2, 2020
    Press release - Non-regulatory

    Targovax is invited to present at Pareto Nordic Healthcare conference and RAS-targeted drug development summit

    August 31, 2020
    Press release - Regulatory

    Targovax ASA: Settlement of restricted stock units by primary insider and resolution to increase the share capital

    August 20, 2020
    Press release - Regulatory

    Targovax ASA: second quarter and first half 2020 results

    August 12, 2020
    Press release - Non-regulatory

    Targovax ASA: Invitation to presentation of Targovax’s second quarter and first half 2020 results, Thursday 20 August

    June 29, 2020
    Press release - Non-regulatory

    Targovax and Oblique enter collaboration to target mutant RAS cancers by combining their ONCOS and Abiprot™ platforms

    June 24, 2020
    Press release - Non-regulatory

    Targovax announces presentation of pre-clinical data from Next Generation ONCOS at AACR Virtual Annual Conference

    June 23, 2020
    Press release - Non-regulatory

    Targovax announces collaboration to evaluate ONCOS-102 in combination with KEYTRUDA® in mesothelioma

    June 22, 2020
    Press release - Non-regulatory

    Targovax to present at the upcoming 2020 Virtual European Biotech Investor Day 2020

    June 22, 2020
    Press release - Non-regulatory

    Targovax’s ONCOS-102 mesothelioma 12-month data powerfully demonstrate broad immune activation linked to clinical benefit

    June 4, 2020
    Press release - Non-regulatory

    Targovax enters collaboration with Leidos to add checkpoint inhibitor functionality to ONCOS viruses

    May 14, 2020
    Press release - Non-regulatory

    Targovax announces that the ONCOS-102 and durvalumab abstract is selected for a Poster Discussion Session at ASCO

    May 7, 2020
    Press release - Regulatory

    Targovax ASA: First quarter 2020 results

    May 6, 2020
    Press release - Non-regulatory

    Targovax announces that abstract on interim phase I clinical data from the phase I/II peritoneal trial is accepted at ASCO

    May 5, 2020
    Press release - Regulatory

    Targovax ASA issues options to new member of management

    May 4, 2020
    Press release - Non-regulatory

    Targovax releases update for mesothelioma trial combining ONCOS-102 and chemotherapy

    April 30, 2020
    Press release - Non-regulatory

    Targovax ASA appoints Dr Victor Levitsky as Chief Scientific Officer

    April 30, 2020
    Press release - Regulatory

    Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

    April 29, 2020
    Press release - Non-regulatory

    Targovax ASA: Minutes from the Annual General Meeting

    April 29, 2020
    Press release - Non-regulatory

    Targovax ASA: Invitation to online presentation of Targovax’s first quarter 2020 results, Thursday 7 May

    April 22, 2020
    Press release - Non-regulatory

    Targovax and Valo Therapeutics enter collaboration to develop RAS neoantigen coating of ONCOS viruses using PeptiCRAd technology

    April 3, 2020
    Press release - Non-regulatory

    Targovax ASA announces proposed new Chairman of the Board

    April 2, 2020
    Press release - Non-regulatory

    Notice of Annual General Meeting

    March 30, 2020
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following settlement of restricted stock units

    March 26, 2020
    Press release - Regulatory

    Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

    March 26, 2020
    Press release - Non-regulatory

    Targovax to present at the 2020 Solebury Trout Virtual Investor Conference today

    March 23, 2020
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insiders in connection with settlement of RSUs

    March 20, 2020
    Press release - Non-regulatory

    Impact of corona virus (COVID-19) on Targovax’s operations

    March 11, 2020
    Press release - Regulatory

    Targovax ASA: Fourth quarter 2019 results

    March 11, 2020
    Press release - Regulatory

    Targovax ASA: Annual Report 2019

    March 3, 2020
    Press release - Non-regulatory

    Targovax announces completed enrollment in the ONCOS-102 trial in anti-PD1 refractory melanoma

    March 3, 2020
    Press release - Non-regulatory

    Targovax ASA: Invitation to presentation of Targovax’s fourth quarter 2019 results, Wednesday 11 March

    January 31, 2020
    Press release - Regulatory

    TARGOVAX ASA – NO SUBSEQUENT OFFERING

    January 28, 2020
    Press release - Regulatory

    TARGOVAX ASA – REGISTRATION OF SHARE CAPITAL INCREASE FOLLOWING THE PRIVATE PLACEMENT

    January 22, 2020
    Press release - Regulatory

    TARGOVAX ASA – KEY INFORMATION RELATED TO THE SUBSEQUENT OFFERING

    January 22, 2020
    Press release - Regulatory

    TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

    January 22, 2020
    Press release - Regulatory

    TARGOVAX ASA – CONTEMPLATED PRIVATE PLACEMENT

    January 22, 2020
    Press release - Non-regulatory

    Reminder: Targovax ASA – Invitation to investor call

    January 21, 2020
    Press release - Non-regulatory

    Targovax ASA: Invitation to investor call

    January 21, 2020
    Press release - Non-regulatory

    Targovax announces encouraging data in mesothelioma study combining ONCOS-102 and standard of care chemotherapy

    January 8, 2020
    Press release - Non-regulatory

    Targovax and IOVaxis Therapeutics enters Option Agreement for TG mutant RAS vaccine license and clinical development in China

    December 19, 2019
    Press release - Regulatory

    Targovax ASA issues options to employees

    November 28, 2019
    Press release - Regulatory

    Targovax ASA: Primary insider share purchase

    November 11, 2019
    Press release - Non-regulatory

    Presentation of ONCOS-102 melanoma data at SITC Annual Meeting

    November 7, 2019
    Press release - Regulatory

    Targovax ASA: Third quarter 2019 results

    October 29, 2019
    Press release - Non-regulatory

    Targovax ASA: Invitation to presentation of Targovax’s third quarter 2019 results, Thursday 7 November

    October 9, 2019
    Press release - Non-regulatory

    Targovax selected for oral presentation at Society for Immunotherapy of Cancer (SITC) 2019 Annual Meeting

    September 24, 2019
    Press release - Non-regulatory

    Targovax announces opening of Oslo University Hospital as site for ONCOS-102 trial in melanoma

    September 18, 2019
    Press release - Regulatory

    Correction: Targovax Q2 2019 report

    August 22, 2019
    Press release - Regulatory

    Targovax ASA: Second quarter and first half 2019 results

    August 12, 2019
    Press release - Non-regulatory

    Targovax ASA: Announcement of second quarter and first half results 2019

    July 31, 2019
    Press release - Non-regulatory

    Targovax is invited to present at Solebury Trout European Biotech Investor Day in NYC

    July 15, 2019
    Press release - Non-regulatory

    Targovax announces start of the expansion part in the phase I/II trial with ONCOS-102 in combination with durvalumab in patients with advanced peritoneal malignancies

    July 9, 2019
    Press release - Regulatory

    Targovax ASA: Notification of trade by primary insiders

    July 8, 2019
    Press release - Regulatory

    Targovax announces encouraging results from part 1 of the ONCOS-102 and Keytruda combination trial in anti-PD1 refractory melanoma

    June 18, 2019
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following settlement of RSUs

    June 13, 2019
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider following settlement of RSUs

    June 12, 2019
    Press release - Regulatory

    Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

    June 6, 2019
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

    June 6, 2019
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

    June 5, 2019
    Press release - Regulatory

    Targovax ASA: Completion of subsequent offering, registration of share capital increase

    June 3, 2019
    Press release - Non-regulatory

    Targovax announces publication of in vivo abscopal effect of ONCOS-102 and Keytruda combination

    May 31, 2019
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

    May 28, 2019
    Press release - Regulatory

    Targovax ASA: Final result of the subsequent offering

    May 24, 2019
    Press release - Regulatory

    Targovax ASA: Last day of the subscription period in the subsequent offering

    May 23, 2019
    Press release - Regulatory

    TARGOVAX ASA – APPROVAL AND PUBLICATION OF SUPPLEMENTAL PROSPECTUS

    May 23, 2019
    Press release - Regulatory

    Targovax to fully focus on ONCOS oncolytic virus program

    May 23, 2019
    Press release - Regulatory

    Targovax announces median and three-year overall survival for TG01 trial in resected pancreatic cancer

    May 10, 2019
    Press release - Regulatory

    Targovax ASA: Commencement of subscription period in the subsequent offering

    May 9, 2019
    Press release - Regulatory

    Targovax ASA: First quarter 2019 results

    May 8, 2019
    Press release - Non-regulatory

    Targovax announces completed enrollment of ONCOS-102 trial in mesothelioma

    May 2, 2019
    Press release - Regulatory

    Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

    April 30, 2019
    Press release - Regulatory

    Targovax ASA: Minutes from the Annual General Meeting

    April 30, 2019
    Press release - Non-regulatory

    Targovax ASA: Announcement of first quarter 2019

    April 12, 2019
    Press release - Regulatory

    TARGOVAX ASA – APPROVAL AND PUBLICATION OF SUPPLEMENTAL PROSPECTUS

    April 9, 2019
    Press release - Regulatory

    Targovax ASA: Annual Report 2018

    April 9, 2019
    Press release - Regulatory

    Notice of Annual General Meeting

    March 28, 2019
    Press release - Regulatory

    TARGOVAX ASA – REGISTRATION OF SHARE CAPITAL INCREASE FOLLOWING THE PRIVATE PLACEMENT

    March 27, 2019
    Press release - Regulatory

    TARGOVAX ASA – APPROVAL AND PUBLICATION OF PROSPECTUS

    March 25, 2019
    Press release - Regulatory

    Targovax to hold a webcast with Q&A session

    March 21, 2019
    Press release - Regulatory

    TARGOVAX ASA – NOTIFICATION OF SHAREHOLDING

    March 21, 2019
    Press release - Regulatory

    TARGOVAX ASA – KEY INFORMATION RELATED TO THE SUBSEQUENT OFFERING

    March 21, 2019
    Press release - Regulatory

    TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

    March 21, 2019
    Press release - Regulatory

    TARGOVAX ASA – CONTEMPLATED PRIVATE PLACEMENT

    March 19, 2019
    Press release - Non-regulatory

    Targovax is invited to present at Neoantigen Summit Europe, DNB SME Conference and BIO-Europe Spring

    March 15, 2019
    Press release - Regulatory

    Targovax signs clinical collaboration agreement with the Parker Institute for Cancer Immunotherapy and Cancer Research Institute

    March 14, 2019
    Press release - Non-regulatory

    Targovax grants Zelluna Immunotherapy an FTO license to intellectual property relating to mutant RAS T cell receptor technology

    March 8, 2019
    Press release - Non-regulatory

    Targovax announces Notice of Allowance in the US on patent covering the TG mutant-RAS neoantigen vaccine platform

    February 14, 2019
    Press release - Regulatory

    Targovax ASA: Fourth quarter and full year 2018 results

    February 11, 2019
    Press release - Non-regulatory

    First patient treated in dose expansion cohort of Targovax’s ONCOS-102 trial in melanoma

    February 4, 2019
    Press release - Non-regulatory

    Targovax ASA: Announcement of fourth quarter and full year results 2018

    January 21, 2019
    Press release - Non-regulatory

    Targovax is invited to present at upcoming investor conferences

    January 17, 2019
    Press release - Non-regulatory

    Targovax granted European Patent for mutant-RAS neoantigen platform lead products

    January 3, 2019
    Press release - Regulatory

    Targovax ASA issues options to employees

    December 12, 2018
    Press release - Regulatory

    Targovax Presents at DNB 9th Annual Nordic Healthcare Conference

    November 28, 2018
    Press release - Non-regulatory

    Targovax is invited to present at upcoming investor and industry conferences

    November 16, 2018
    Press release - Non-regulatory

    Targovax to present at NeoAg Summit 2018

    November 1, 2018
    Press release - Regulatory

    Targovax ASA: Third quarter 2018 results

    October 26, 2018
    Press release - Regulatory

    Targovax ASA: Announcement of third quarter 2018 financial results

    October 15, 2018
    Press release - Non-regulatory

    Targovax reports encouraging disease-free survival (DFS) data from TG01 trial in resected pancreatic cancer

    October 12, 2018
    Press release - Regulatory

    Agenda for Targovax Capital Markets Day 15 October 2018, in Oslo, Norway

    October 11, 2018
    Press release - Regulatory

    Targovax Key Opinion Leader Symposium on Oncolytic Viruses in New York City today, 11 October, 2018

    October 4, 2018
    Press release - Regulatory

    Targovax to host Capital Markets Day 15 October 2018, in Oslo, Norway

    October 1, 2018
    Press release - Regulatory

    Targovax presented ONCOS-102 poster at 13th International Adenovirus Meeting

    September 27, 2018
    Press release - Regulatory

    Targovax announces interim results from Phase I trial of ONCOS-102 in checkpoint inhibitor refractory melanoma

    September 27, 2018
    Press release - Regulatory

    Targovax to Host Key Opinion Leader Symposium on Oncolytic Viruses in New York City, 11 October 2018

    September 25, 2018
    Press release - Regulatory

    Targovax ASA: Issuance of options to primary insider

    September 13, 2018
    Press release - Regulatory

    Targovax strengthens management team with the appointment of Torbjørn Furuseth as CFO; Erik Digman Wiklund to become CBO

    September 12, 2018
    Press release - Regulatory

    Targovax announces publication of new oncolytic virus data in the Journal of Medical Virology and Cancer Gene Therapy

    September 4, 2018
    Press release - Regulatory

    Targovax ASA: Registration of new share capital following settlement of restricted stock units

    August 29, 2018
    Press release - Regulatory

    Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

    August 23, 2018
    Press release - Regulatory

    Targovax ASA: Second quarter and first half year 2018 results

    August 15, 2018
    Press release - Regulatory

    Targovax ASA: Invitation to second quarter and first half year 2018 results presentation Thursday 23 August

    July 12, 2018
    Press release - Regulatory

    Targovax and SOTIO announce first patient dosed in Phase I/II combination trial of ONCOS-102 with DCVAC

    June 20, 2018
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade – primary insider

    June 19, 2018
    Press release - Regulatory

    Targovax granted EU Patent for mutant-RAS neoantigen platform 2nd generation product TG02

    June 12, 2018
    Press release - Regulatory

    Targovax hosts conference call 12 June 2018

    June 11, 2018
    Press release - Regulatory

    Targovax strengthens focus on ONCOS oncolytic virus development program

    June 4, 2018
    Press release - Regulatory

    Targovax to Present at Jefferies 2018 Global Healthcare Conference

    May 24, 2018
    Press release - Regulatory

    Targovax strengthens 2-year survival rate in resected pancreatic cancer with TG01

    May 16, 2018
    Press release - Regulatory

    Targovax to present at upcoming investor and industry conferences

    May 3, 2018
    Press release - Regulatory

    Targovax ASA: First quarter 2018 results

    May 2, 2018
    Press release - Regulatory

    Targovax announces early signal of efficacy in ONCOS-102 trial in mesothelioma

    April 25, 2018
    Press release - Regulatory

    Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

    April 25, 2018
    Press release - Non-regulatory

    Targovax presentation at ChinaBio Partnering Forum 2018

    April 24, 2018
    Press release - Regulatory

    Targovax ASA: Invitation to first quarter 2018 results presentation Thursday 3 May

    April 12, 2018
    Press release - Regulatory

    Targovax strengthens Board of Directors with the appointment of Catherine Wheeler

    April 11, 2018
    Press release - Regulatory

    Targovax ASA: Protocol from the Annual General Meeting

    March 24, 2018
    Press release - Regulatory

    Targovax ASA: Proposal from the nomination committee to the annual general meeting 11 April 2018

    March 15, 2018
    Press release - Regulatory

    Targovax ASA: Notice of Annual General Meeting

    March 15, 2018
    Press release - Regulatory

    Targovax ASA: Annual Report 2017

    March 1, 2018
    Press release - Regulatory

    Targovax ASA: Issuance of restricted stock unites (RSUs) to the chairman of the board of directors

    February 27, 2018
    Press release - Non-regulatory

    Targovax to present at Biologics World Nordic 2018

    February 15, 2018
    Press release - Regulatory

    Targovax ASA: Fourth quarter and full year 2017 results

    February 7, 2018
    Press release - Regulatory

    Targovax announces completion of safety lead-in and preliminary immune activation data in ONCOS-102 trial in mesothelioma

    February 6, 2018
    Press release - Regulatory

    Targovax ASA: Invitation to fourth quarter and full year 2017 results presentation Thursday 15 February

    February 2, 2018
    Press release - Regulatory

    Targovax ASA: Exercise price of options

    February 1, 2018
    Press release - Regulatory

    Targovax ASA issues options to employees

    January 8, 2018
    Press release - Regulatory

    Targovax announces the appointment of Michael Bogenstaetter as Chief Business Officer

    January 4, 2018
    Press release - Regulatory

    Targovax announces that ONCOS-102 generates immune activation in checkpoint inhibitor refractory melanoma patients

    December 18, 2017
    Press release - Regulatory

    Targovax announces that TG02 has passed the initial safety review in the first-in-man clinical trial in colorectal cancer

    December 13, 2017
    Press release - Non-regulatory

    Targovax to present at DNB healthcare conference

    December 11, 2017
    Press release - Regulatory

    Targovax announces that first combination trials with ONCOS-102 have passed their initial, planned, independent safety reviews

    November 30, 2017
    Press release - Regulatory

    Targovax ASA: New member of the board of directors

    November 14, 2017
    Press release - Regulatory

    Targovax to present at upcoming investor conferences

    November 7, 2017
    Press release - Regulatory

    Targovax ASA: Notice of Extraordinary General Meeting

    November 3, 2017
    Press release - Regulatory

    Targovax ASA: Exercise of employee share options and restricted stock units in Targovax ASA

    November 2, 2017
    Press release - Regulatory

    Targovax ASA: Third quarter 2017 results

    October 27, 2017
    Press release - Regulatory

    Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

    October 24, 2017
    Press release - Regulatory

    Targovax ASA: Invitation to third quarter 2017 results presentation Thursday 2 November

    October 12, 2017
    Press release - Regulatory

    Targovax announces one-year survival rate and safety data in the modified cohort of the TG01 trial in resected pancreatic cancer

    October 3, 2017
    Press release - Regulatory

    Targovax granted US Patent for mutant-RAS neoantigen platform 2nd generation product TG02

    September 25, 2017
    Press release - Regulatory

    Targovax granted US Patent for mutant-RAS neoantigen platform lead products

    September 14, 2017
    Press release - Regulatory

    Targovax Receives 2017 Nordic Stars Award

    September 12, 2017
    Press release - Regulatory

    Targovax announces start of patient recruitment in phase I/II study with ONCOS-102 in combination with durvalumab in patients with advanced peritoneal malignancies

    September 11, 2017
    Press release - Non-regulatory

    Targovax ASA: Three posters presented at ESMO conference

    August 29, 2017
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following exercise of employee options and settlement of restricted stock units

    August 28, 2017
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

    August 25, 2017
    Press release - Regulatory

    Exercise of employee share options and restricted stock units in Targovax ASA

    August 24, 2017
    Press release - Regulatory

    Targovax ASA: Second quarter and first half 2017 results

    August 23, 2017
    Press release - Non-regulatory

    Targovax ASA: Abstracts accepted for poster presentation at the ESMO 2017 Congress

    August 18, 2017
    Press release - Regulatory

    Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

    August 14, 2017
    Press release - Regulatory

    Targovax ASA: Invitation to second quarter and first half 2017 results presentation Thursday 24 August

    July 17, 2017
    Press release - Regulatory

    Targovax ASA: Final result of the subsequent offering

    July 14, 2017
    Press release - Regulatory

    Targovax ASA: Preliminary result of the subsequent offering

    July 14, 2017
    Press release - Regulatory

    Targovax ASA: Last day of the subscription period in the subsequent offering

    July 7, 2017
    Press release - Regulatory

    Targovax ASA: Notification of trade by primary insiders

    July 6, 2017
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following the private placement

    July 3, 2017
    Press release - Regulatory

    Targovax ASA: Commencement of subscription period for the subsequent offering

    June 30, 2017
    Press release - Regulatory

    Targovax ASA: Approval and publication of prospectus; the subsequent offering

    June 30, 2017
    Press release - Regulatory

    Targovax ASA: Extraordinary general meeting held, approval of private placement and subsequent offering

    June 26, 2017
    Press release - Regulatory

    Targovax ASA: Registration of capital increase following exercise of employee options and settlement of restricted stock units

    June 22, 2017
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in relation to exercise of employee options

    June 22, 2017
    Press release - Regulatory

    Targovax ASA: Exercise of employee share options and settlement of restricted stock units in Targovax ASA

    June 15, 2017
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of vested restricted stock units

    June 14, 2017
    Press release - Regulatory

    Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

    June 9, 2017
    Press release - Regulatory

    Targovax ASA: Notice of Extraordinary General Meeting

    June 9, 2017
    Press release - Regulatory

    Targovax ASA – Information on the subsequent offering – Key date information

    June 8, 2017
    Press release - Regulatory

    TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

    June 8, 2017
    Press release - Regulatory

    TARGOVAX ASA – CONTEMPLATED PRIVATE PLACEMENT

    June 6, 2017
    Press release - Regulatory

    Targovax presents further positive clinical data from TG01 phase I/II trial at 2017 ASCO annual meeting

    June 6, 2017
    Press release - Regulatory

    Targovax announces formal agenda for 2017 Capital Markets Updates in Oslo and London

    May 18, 2017
    Press release - Regulatory

    Targovax ASA: ASCO abstract released

    May 10, 2017
    Press release - Regulatory

    Targovax recruits first patient into first ONCOS-102 /Checkpoint inhibitor melanoma study

    May 8, 2017
    Press release - Regulatory

    Targovax ASA: Capital Markets Updates in Oslo on Thursday 8 June and in London on Monday 26 June 2017

    April 28, 2017
    Press release - Regulatory

    Targovax ASA: Issuance of restricted stock unites (RSUs) to the board members

    April 25, 2017
    Press release - Regulatory

    Targovax ASA: First quarter 2017 results

    April 20, 2017
    Press release - Regulatory

    Targovax initiates first clinical trial with TG02, the second product from its RAS-peptide immunotherapy platform

    April 19, 2017
    Press release - Regulatory

    Targovax ASA: Invitation to first quarter 2017 results presentation Tuesday 25 April

    April 6, 2017
    Press release - Regulatory

    Targovax to present clinical data on its phase I/II clinical trial evaluating TG01 in resected pancreatic cancer at the ASCO Annual Meeting

    April 5, 2017
    Press release - Regulatory

    Targovax ASA: Protocol from the Annual General Meeting

    April 4, 2017
    Press release - Regulatory

    Targovax ASA: Proposal from the nomination committee to the annual general meeting 5 April 2017

    April 4, 2017
    Press release - Regulatory

    Targovax ASA: Grant of share options

    March 23, 2017
    Press release - Regulatory

    Targovax ASA moves share listing to Oslo Børs

    March 22, 2017
    Press release - Regulatory

    Targovax ASA: Approval and publication listing prospectus

    March 22, 2017
    Press release - Regulatory

    Targovax ASA: The board of directors of Oslo Stock Exchange approves transfer of Targovax ASA to the main list

    March 17, 2017
    Press release - Regulatory

    Targovax ASA applies for transfer to Oslo Stock Exchange main list

    March 15, 2017
    Press release - Regulatory

    Targovax ASA: Notice of Annual General Meeting

    March 15, 2017
    Press release - Regulatory

    Targovax ASA: Annual Report 2016

    March 6, 2017
    Press release - Non-regulatory

    Targovax to present at upcoming conferences

    February 24, 2017
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following exercise of employee options and settlement of restricted stock units

    February 24, 2017
    Press release - Regulatory

    Targovax ASA: Exercise of employee share options and restricted stock units in Targovax ASA

    February 16, 2017
    Press release - Regulatory

    Targovax ASA: Fourth quarter and full year 2016 results

    February 13, 2017
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of restricted stock units

    February 10, 2017
    Press release - Regulatory

    Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

    February 6, 2017
    Press release - Regulatory

    Targovax ASA: Invitation to fourth quarter and full year 2016 results presentation Thursday 16 February

    February 2, 2017
    Press release - Regulatory

    Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients

    January 5, 2017
    Press release - Regulatory

    Targovax announces appointment of Erik Digman Wiklund as CFO

    December 13, 2016
    Press release - Non-regulatory

    Targovax to present at DNB healthcare conference

    December 9, 2016
    Press release - Regulatory

    Targovax ASA: Grant of share options

    November 21, 2016
    Press release - Regulatory

    Targovax ASA: Registration of share capital increase following exercise of employee options

    November 21, 2016
    Press release - Regulatory

    Targovax ASA: Exercise of employee share options in Targovax ASA

    November 18, 2016
    Press release - Regulatory

    Targovax ASA: Mandatory notification of trade by primary insider

    November 17, 2016
    Press release - Regulatory

    Targovax ASA: Third quarter 2016 results

    November 16, 2016
    Press release - Non-regulatory

    Targovax to present at forthcoming conference

    November 10, 2016
    Press release - Regulatory

    Targovax granted European Patent for ONCOS platform lead product, ONCOS-102

    November 8, 2016
    Press release - Regulatory

    Targovax ASA: Invitation to third quarter 2016 results presentation Thursday 17 November

    November 4, 2016
    Press release - Regulatory

    Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

    November 2, 2016
    Press release - Non-regulatory

    Targovax ASA: GRANT OF SHARE OPTIONS

    November 2, 2016
    Press release - Non-regulatory

    Targovax ASA: GRANT OF SHARE OPTIONS

    November 2, 2016
    Press release - Non-regulatory

    Targovax announces appointment of Oystein Soug as CEO

    October 21, 2016
    Press release - Non-regulatory

    Targovax presents ONCOS-102 scientific rationale at the European Society of Gene and Cell Therapy

    October 17, 2016
    Press release - Non-regulatory

    Targovax to Present at the ESGCT/ISSCR Stem Cells & Gene Therapy Symposium

    September 19, 2016
    Press release - Non-regulatory

    Targovax to present at Redeye’s Fight Cancer conference

    September 14, 2016
    Press release - Non-regulatory

    Targovax to present at forthcoming conferences

    August 25, 2016
    Press release - Regulatory

    Targovax ASA: Interim Report second quarter and first half year 2016

    August 17, 2016
    Press release - Non-regulatory

    Targovax ASA: Completion of subsequent offering, registration of share capital increase

    August 17, 2016
    Press release - Non-regulatory

    Targovax ASA: Completion of subsequent offering, registration of share capital increase

    August 15, 2016
    Press release - Regulatory

    Targovax ASA: Invitation to second quarter 2016 results presentation Thursday 25 August

    August 9, 2016
    Press release - Non-regulatory

    Targovax ASA: Allocations to primary insiders in the subsequent offering

    August 9, 2016
    Press release - Non-regulatory

    Targovax ASA: Result of the subsequent offering

    August 9, 2016
    Press release - Non-regulatory

    Targovax ASA: Allocations to primary insiders in the subsequent offering

    August 9, 2016
    Press release - Non-regulatory

    Targovax ASA: Result of the subsequent offering

    August 8, 2016
    Press release - Non-regulatory

    Targovax ASA – Last day of the subscription period in the subsequent offering

    August 8, 2016
    Press release - Non-regulatory

    Targovax ASA – Last day of the subscription period in the subsequent offering

    August 4, 2016
    Press release - Non-regulatory

    Anne-Sophie Møller joins Targovax

    August 4, 2016
    Press release - Non-regulatory

    Anne-Sophie Møller joins Targovax

    August 4, 2016
    Press release - Non-regulatory

    Targovax ASA – The subscription period in the subsequent offering expires on Monday 8 August at 16:30 CET

    August 4, 2016
    Press release - Non-regulatory

    Targovax ASA – The subscription period in the subsequent offering expires on Monday 8 August at 16:30 CET

    July 11, 2016
    Press release - Non-regulatory

    Targovax ASA: Commencement of subscription period for the subsequent offering

    July 8, 2016
    Press release - Non-regulatory

    Targovax ASA: Publication of prospectus, listing on Oslo Axess and subsequent offering

    July 7, 2016
    Press release - Non-regulatory

    Targovax ASA: Completion of private placement, registration of share capital increase

    July 6, 2016
    Press release - Non-regulatory

    Targovax ASA: Extraordinary general meeting held, approval of private placement and subsequent offering

    July 6, 2016
    Press release - Regulatory

    Targovax presents encouraging preclinical data on ONCOS-102

    July 1, 2016
    Press release - Non-regulatory

    Targovax recruits the first patient in a trial with the oncolytic virus ONCOS-102 in malignant pleural mesothelioma

    July 1, 2016
    Press release - Regulatory

    Targovax recruits the first patient in a trial with the oncolytic virus ONCOS-102 in malignant pleural mesothelioma

    June 22, 2016
    Press release - Non-regulatory

    Notice of Extraordinary General Meeting

    June 22, 2016
    Press release - Non-regulatory

    Targovax ASA: Announcement of successful NOK 110 million private placement

    June 21, 2016
    Press release - Non-regulatory

    Targovax ASA: Update on bookbuilding for the private placement of NOK 100 – 130 million

    June 20, 2016
    Press release - Non-regulatory

    Targovax ASA: Contemplated private placement of NOK 100 – 130 million

    June 14, 2016
    Press release - Regulatory

    Targovax granted US Patent for oncolytic virus ONCOS-102

    June 9, 2016
    Press release - Regulatory

    Targovax receives regulatory approval in Spain to conduct a clinical trial with its oncolytic virus ONCOS-102

    June 7, 2016
    Press release - Regulatory

    Targovax ASA: Patient recruitment for TG01 immuno-oncology trial completed

    June 2, 2016
    Press release - Regulatory

    Targovax receives approval in Australia to conduct a clinical trial with TG02 – an immunotheraphy treatment targeting RAS mutations

    May 31, 2016
    Press release - Non-regulatory

    Targovax to present at forthcoming conferences

    May 20, 2016
    Press release - Non-regulatory

    Magnus Jaderberg, CMO of Targovax, has presented at a symposium by The Royal Swedish Academy of Engineering Sciences

    May 12, 2016
    Press release - Regulatory

    Targovax ASA: Interim report first quarter 2016

    May 9, 2016
    Press release - Regulatory

    Targovax to present at BioEquity Europe and its first quarter 2016 results on May 11 – 12, 2016

    May 9, 2016
    Press release - Non-regulatory

    Targovax ASA: Registration of share capital increase following exercise of employee options

    April 29, 2016
    Press release - Non-regulatory

    Exercise of employee share options in Targovax ASA

    April 16, 2016
    Press release - Non-regulatory

    Annual Report 2015

    April 15, 2016
    Press release - Non-regulatory

    Targovax ASA: Grant of restricted stock units to the Board of directors

    April 14, 2016
    Press release - Regulatory

    Targovax reports immune response with reduced number of TG01 vaccinations

    April 14, 2016
    Press release - Non-regulatory

    Resolution to increase the share capital in Targovax ASA in relation to exercise of employee options

    March 15, 2016
    Press release - Non-regulatory

    Targovax to present at forthcoming Life Science and Investor conferences

    March 14, 2016
    Press release - Regulatory

    Targovax to present at forthcoming Life Science and Investor conferences

    March 14, 2016
    Press release - Non-regulatory

    Sachs Zürich March 2016

    March 11, 2016
    Press release - Non-regulatory

    Targovax in Dagens Medisin

    March 10, 2016
    Press release - Regulatory

    Targovax announces encouraging interim results with RAS specific peptide vaccine in resected pancreatic cancer

    March 7, 2016
    Press release - Non-regulatory

    Targovax in BioCentury cover story

    March 2, 2016
    Press release - Regulatory

    Targovax ASA: Interim report fourth quarter 2015

    February 25, 2016
    Press release - Regulatory

    CORRECTION: Targovax ASA: Invitation to Fourth Quarter 2015 Results Presentation

    February 25, 2016
    Press release - Regulatory

    Targovax ASA: Invitation to Fourth Quarter 2015 Results Presentation

    February 2, 2016
    Press release - Regulatory

    Targovax submits a study of its adenovirus based immune therapy ONCOS-102 to the regulatory authorities in Spain

    December 14, 2015
    Press release - Non-regulatory

    DNB’s 6th Annual Health Care Conference, Oslo, 15 December 2015

    December 9, 2015
    Press release - Non-regulatory

    Exercise of employee share options

    November 26, 2015
    Press release - Regulatory

    Targovax ASA: Interim report third quarter 2015

    November 19, 2015
    Press release - Regulatory

    Targovax ASA: Invitation to presentation of Targovax’ third quarter 2015 results

    November 18, 2015
    Press release - Regulatory

    Targovax ASA: LUDWIG CANCER RESEARCH AND CANCER RESEARCH INSTITUTE PARTNER WITH TARGOVAX TO TEST CANDIDATE VIROTHERAPY IN EARLY-PHASE CLINICAL TRIALS

    November 6, 2015
    Press release - Regulatory

    Targovax to present at upcoming investor Conferences

    November 5, 2015
    Press release - Regulatory

    Targovax ASA: Immunotherapy with ONCOS-102 show potential to activate immunologically silent tumors and reduce local immune suppression in advanced tumors

    September 14, 2015
    Press release - Non-regulatory

    Protocol from Extraordinary General Meeting

    September 14, 2015
    Press release - Non-regulatory

    Targovax appoints two new directors to its board

    August 28, 2015
    Press release - Non-regulatory

    Targovax AS: Interim Report Q2 and 1H 2015

    August 27, 2015
    Press release - Non-regulatory

    Notice of Extraordinary General Meeting

    July 9, 2015
    Press release - Non-regulatory

    Completion of NOK 200 million private placement

    July 2, 2015
    Press release - Non-regulatory

    Targovax AS: Closing of the acquisition of Oncos Therapeutics Oy

    June 22, 2015
    Press release - Non-regulatory

    Protocol from general Meeting

    June 18, 2015
    Press release - Non-regulatory

    Targovax announces successful NOK 200 million private placement

    June 15, 2015
    Press release - Non-regulatory

    Targovax increases size of private placement to NOK 200 million after strong investor demand

    June 11, 2015
    Press release - Non-regulatory

    Notice of Extraordinary General Meeting

    June 11, 2015
    Press release - Non-regulatory

    Targovax and Oncos Therapeutics join forces to create a Nordic leader within immuno-oncology

    June 2, 2015
    Press release - Non-regulatory

    ASCO poster 2015

    June 1, 2015
    Press release - Non-regulatory

    Targovax presented safety data and immunological results at the 2015 ASCO Annual Meeting

    May 18, 2015
    Press release - Non-regulatory

    Targovax presents data at ASCO 2015 in Chicago

    May 12, 2015
    Press release - Non-regulatory

    Targovax AS: Interim Report Q1 2015

    May 7, 2015
    Press release - Non-regulatory

    MEET US: Bio-International, Philadephia, June 14-18 2015

    May 7, 2015
    Press release - Non-regulatory

    MEET US: ASCO, Chicago, June 1-3 2015

    April 28, 2015
    Press release - Non-regulatory

    Protocol from general Meeting

    April 20, 2015
    Press release - Non-regulatory

    Notice of general assembly

    April 20, 2015
    Press release - Non-regulatory

    Targovax ASA: Oncos Therapeutics presenting at the Anglonordic Life Science Conference on April 23rd in London, UK.

    April 17, 2015
    Press release - Regulatory

    Annual report 2014 – IFRS

    April 16, 2015
    Press release - Regulatory

    Annual report 2014 – NGAAP

    April 13, 2015
    Press release - Non-regulatory

    Targovax has appointed Peter Skorpil as Head of Business Development, effective from April 8th, 2015.

    April 1, 2015
    Press release - Non-regulatory

    Targovax Presentation Arctic Biotech Seminar March 2015

    March 9, 2015
    Press release - Non-regulatory

    Targovax has decided to expand the on-going phase I/II clinical study CT-TG01-01 with a new group of up to 13 patients.

    February 26, 2015
    Press release - Non-regulatory

    Targovax ASA: Oncos represented at the 8th Annual Life Science CEO Forum & Exhibition March 3rd, 2015 in Zurich, Switzerland

    February 26, 2015
    Press release - Non-regulatory

    Targovax is pleased to announce Mr. Øystein Soug as the new CFO of the Company from June 1, 2015

    February 16, 2015
    Press release - Non-regulatory

    Interim Report Q4 and YTD 2014

    February 11, 2015
    Press release - Non-regulatory

    Protocol from general Meeting

    February 3, 2015
    Press release - Non-regulatory

    Notice of Extraordinary General Meeting

    January 26, 2015
    Press release - Non-regulatory

    Targovax ASA: ONCOS-102 Mechanism of Action -video released on the website

    January 22, 2015
    Press release - Non-regulatory

    Targovax strengthens management team

    January 12, 2015
    Press release - Non-regulatory

    Targovax ASA: ONCOS-102 granted US lung cancer orphan drug designation

    January 8, 2015
    Press release - Non-regulatory

    Targovax reports completion of recruitment of patients in the phase I/II clinical trial CT TG01-01

    December 31, 2014
    Press release - Non-regulatory

    Targovax AS: Interim Report Q4 and YTD 2014

    December 17, 2014
    Press release - Non-regulatory

    Targovax ASA: “ONCOS-102 sensitizes tumors to other immunotherapies” – Paper published in the latest issue of OncoImmunology

    December 1, 2014
    Press release - Non-regulatory

    Targovax awarded an immuno-oncology innovation prize

    November 25, 2014
    Press release - Non-regulatory

    Targovax ASA: Oncos Therapeutics receives a positive opinion on orphan drug designation for ONCOS-102

    November 21, 2014
    Press release - Non-regulatory

    Targovax AS: Interim Report Q3 and YTD 2014

    November 20, 2014
    Press release - Non-regulatory

    Targovax ASA: Oncos presented a poster at EORTC-NCI-AACR Meeting 2014

    November 10, 2014
    Press release - Non-regulatory

    Targovax ASA: Oncos presented a poster at the SITC Annual Meeting 2014

    November 5, 2014
    Press release - Non-regulatory

    Targovax ASA: Sari Pesonen invited to present a poster at EORTC-NCI-AACR 2014, Nov 18-21, in Barcelona

    November 5, 2014
    Press release - Non-regulatory

    Targovax ASA: Frans Wuite invited to be a panelist in European Business Angel on Nov 17

    November 5, 2014
    Press release - Non-regulatory

    MEET US: DNB Markets Health Care Conference 2014, December 11th 2014, Oslo, Norway

    November 3, 2014
    Press release - Non-regulatory

    Targovax AS has reached primary endpoint for the ongoing phase I/II clinical trial CT TG01-01

    November 3, 2014
    Press release - Non-regulatory

    Targovax AS has reached an important milestone

    October 30, 2014
    Press release - Non-regulatory

    Targovax ASA: Frans Wuite presenting Oncos at Bio Europe 2014 on Nov 5, 2014 in Frankfurt

    October 30, 2014
    Press release - Non-regulatory

    Protocol from general assembly

    October 27, 2014
    Press release - Non-regulatory

    Targovax ASA: Oncos presenting at the fall seminar of Statisticians in Finnish Pharmaceutical Industry held in Turku, Finland Oct 30, 2014

    October 23, 2014
    Press release - Non-regulatory

    Notice of general assembly

    October 8, 2014
    Press release - Non-regulatory

    Targovax ASA:

    October 3, 2014
    Press release - Non-regulatory

    Targovax appoints Gunnar Gårdemyr as new CEO

    October 1, 2014
    Press release - Non-regulatory

    Targovax Presentation Arctic Biotech Day September 2014

    September 11, 2014
    Press release - Non-regulatory

    New member of the Board

    September 11, 2014
    Press release - Non-regulatory

    Protocol from general assembly

    September 3, 2014
    Press release - Non-regulatory

    Notice of general assembly

    September 2, 2014
    Press release - Non-regulatory

    Notice of general assembly

    August 27, 2014
    Press release - Non-regulatory

    Targovax: Interim Report Q2 and YTD 2014

    June 16, 2014
    Press release - Non-regulatory

    Targovax AS is registered on the NOTC-list

    June 4, 2014
    Press release - Non-regulatory

    Targovax ASA: Oncos Therapeutics recruits Dr Magnus Jaderberg as CMO to strengthen its focus on cancer immunotherapy

    June 4, 2014
    Press release - Non-regulatory

    Targovax successfully completes a 70 MNOK financing

    June 2, 2014
    Press release - Non-regulatory

    Oncos Therapeutics granted US and EU Orphan Drug Designation for ONCOS-102 in ovarian cancer

    May 8, 2014
    Press release - Non-regulatory

    Targovax ASA: ONCOS – achievement in cancer immunotherapy – PRESS RELEASE

    April 4, 2014
    Press release - Non-regulatory

    Targovax in Dagens Medisin

    April 1, 2014
    Press release - Non-regulatory

    MEET US: CIMT, Mainz, May 6-8th

    February 28, 2014
    Press release - Non-regulatory

    Targovax ASA: ATMP classification for ONCOS-102 by European Medicines Agency

    February 6, 2014
    Press release - Non-regulatory

    MEET US: BIO-Europe Spring, 2014

    February 6, 2014
    Press release - Non-regulatory

    Targovax TG01 immunotherapy reaches phase IIA in operable pancreatic cancer

    January 31, 2014
    Press release - Non-regulatory

    Targovax ASA: Oncos Therapeutics among Top 20 Finnish startup companies by Talouselämä journal

    October 15, 2013
    Press release - Non-regulatory

    Oncos Therapeutics nominated the Nordic Star Finland by SwedenBIO

    September 15, 2013
    Press release - Non-regulatory

    Professor Hani Gabra joins Clinical Advisory Board of Oncos Therapeutics

    July 31, 2013
    Press release - Non-regulatory

    Oncos Therapeutics granted Orphan Drug Designation for CGTG-102 by FDA and EMA

    June 21, 2013
    Press release - Non-regulatory

    Oncos Therapeutics nominated again among the most promising startup companies

    May 29, 2013
    Press release - Non-regulatory

    Targovax receives 20 MNOK in private and public support

    January 29, 2013
    Press release - Non-regulatory

    First patient included in phase I/II clinical study with TG01 in operable pancreatic cancer

    November 14, 2012
    Press release - Non-regulatory

    Oncos Therapeutics appoints experienced industry leader Frans Wuite as President and CEO

    November 1, 2012
    Press release - Non-regulatory

    TG01 getting ready for phase I/II

    July 5, 2012
    Press release - Non-regulatory

    Oncos Therapeutics Announces Clinical Advisory Board

    May 29, 2012
    Press release - Non-regulatory

    Oncos Therapeutics successfully initiates Phase I clinical study

    March 14, 2012
    Press release - Non-regulatory

    Patient recruitment started in C1 study in Finland (in Finnish)

    January 25, 2012
    Press release - Non-regulatory

    Secures 13 MNOK for development of pancreas cancer vaccine TG01

    November 28, 2011
    Press release - Non-regulatory

    9 million NOK for development of cancer vaccine

    June 13, 2011
    Press release - Non-regulatory

    Targovax AS received a grant from Innovation Norway

    IR contact
    Dr Lubor Gaal
    Dr Lubor Gaal
    Chief Financial Officer
    lubor.gaal@circio.com
    (+34) 683 343 811
    Renate Birkeli
    Renate Birkeli
    Investor Relations
    renate.birkeli@circio.com
    (+47) 922 61 624
    • PRINT
    • STAY CONNECTED
    • Cookies
    • Privacy policy